Filter By:

Choose an area from the filter to limit results to that area and show available options for further filtering

All Funding Schemes

31 schemes

from
Research area remove from filter
  • Call open

    US-Ireland Research and Development Partnership Programme

    Increasing collaboration between United States of America (USA), Republic of Ireland and Northern Ireland researchers

  • Call open

    HRCI-HRB Joint Funding Scheme 2024

    HRCI/HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual charity.

  • Call open

    European Partnership for Personalised Medicine 2024

    The Health Research Board (HRB) and Science Foundation Ireland (SFI) are collaborating to support Irish researchers to engage in transnational collaborative research in the field of personalised medicine under the call entitled “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”.

  • Call open

    Joint Programming Initiative on Antimicrobial Resistance 2024

    The HRB is participating in the JPIAMR Joint Transnational Call 2024 to support Irish researchers to engage in transnational collaborative research in the field of antimicrobial resistance under the call entitled “Interventions Moving forward to Promote ACTion to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments ”.

  • HRB Postdoctoral Fellowships – Applying Research into Policy and Practice (ARPP) 2023

    The overarching aim is to develop talented and skilled health and social care researchers during the postdoctoral stage of their research career, particularly emphasising an ability to apply research evidence to improve healthcare and health policy and reduce the gap between research findings and clinical practice and/or health policy.

  • Summer Student Scholarships (SS) 2024

    Short research projects for undergraduate students in a health or social care-related discipline

  • HRB Impact Award 2023

    The award will recognise a HRB-funded researcher who has led their research to impact/s on policy, practice, services or the health and social care system.

  • Research Leader Awards (RL) 2020 (Next call envisaged in 2025)

    Supporting established health investigators in academic setting transitioning to leadership in health research.

  • Emerging Clinician Scientist Awards (ECSA) 2024

    Supporting health and social care practitioners of any professional background in the Republic of Ireland by facilitating and supporting their transition towards research independence and who can facilitate actionable knowledge in health research.

  • HRB Postdoctoral Fellowships - Clinician Scientist Fellowships (CSF) 2023

    The overarching aim of the CSF scheme is to provide opportunities for talented health and social care practitioners involved in the delivery of patient or social care, who have a PhD (or PhD equivalency) and wish to pursue a combined clinical and research career.

  • Cancer trials in Ireland 2021

    The overall goal of the new funding model for HRBs investment in cancer trials in Ireland is to support an appropriate infrastructure; enabling Irish patients to access a diverse portfolio of high-quality, safe and compliant cancer clinical trials in Ireland.

  • Investigator-Led Projects (ILP) 2024

    The ILP scheme aims to support highly innovative and internationally competitive investigator-led projects that can respond to existing and emerging challenges for health and social care. The ILP provides funding for clearly defined research projects in: (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR).

  • DOROTHY Co-Fund Programme: Postdoctoral Fellowships in Public Health Crisis

    Interdisciplinary postdoctoral fellowships on the topic of public health crisis.

  • Conference and Event Sponsorship Scheme (CES) 2024

    The Conference and Events Sponsorship Scheme aims to create an opportunity to host health research related events, workshops, or conferences in Ireland.

  • Definitive Intervention and Feasibility Awards (DIFA) 2023 - Full Application

    The overarching aim of the Definitive Interventions and Feasibility Awards (DIFA) is to deliver tangible benefits to patients, peoples’ health and health services through the support of studies evaluating a full scale, definitive intervention of any appropriate design to provide high-quality evidence on the efficacy, effectiveness, cost and broad impact of the intervention. To achieve a pipeline of such studies, both definitive interventions and feasibility studies conducted in preparation for future definitive intervention, are supported. The DIFA scheme also supports the conduct of trial methodology research (SWATs) within the context of proposed interventions.

  • Knowledge Translation Awards (KTA) 2022

    The aim of this scheme is to provide HRB funded researchers with an opportunity to seek supplementary funding for knowledge translation activities not covered in the original award that will maximise the potential impact of the research findings on policy or practice or communicate research and research findings to the general public.

  • Fulbright-HRB Health Impact Awards 2024

    Research and/or professional development (between three and six months) in the United States of America (USA).

  • Secondary Data Analysis Projects (SDAP 2023)

    Research projects employing secondary data analysis that supports policy and practice decision making for health and social care.

  • ERA4Health Joint Transnational Call (2023) “Increasing health equity through promoting healthy diets and physical activity (HealthEquity)”

    The aim of this call is to develop novel strategies and targeted approaches to identify, understand, and modify determinants and mechanisms of diet-related behaviour and physical activity as well as sedentary behaviour, which have the potential to break through the cycles maintaining unhealthy behaviours and lifestyles and to reduce health inequities. The expected results have the potential to improve the health and well-being of socio-economically disadvantaged groups through targeted approaches for a long-term behaviour change in the areas of healthy diet and physical activity.

  • Applied Programme Grants (APRO) 2023

    The Applied Programme Grants (APRO) aim to support a strategic programme of applied research in health and social care that will have an impact on the health and social care of individuals, population health and the health system in Ireland and beyond.

  • Patient Safety Research Network (PSRN) 2023

    Bringing together all relevant stakeholders to promote and advance Patient Safety research in Ireland.

  • Transforming Health and Care Systems (THCS) Joint Transnational Call 2023 “Healthcare of the Future”

    The ambition of this call is to identify and develop innovative solutions that can, in the future, help to relieve the pressure on health and care facilities by informing decision-making and optimising the delivery of health and care services across different settings. The complementarity of inpatient and outpatient care, and the coordination between them needs to be optimised. Organisational innovations, continuity of care across all care levels, integrated care and harnessing the potential of supporting digital technologies provide a multitude of possibilities for such optimization, creating opportunities for health and care systems to reap the benefits of distributed health and care. The proposed solutions should aim to make health and care systems economically, socially, and environmentally sustainable, while keeping people at the centre of the care process.

  • Rare Diseases Research and Innovation Catalyst Awards (RDCat) 2023

    The overall aim of the RDCat call is to optimise readiness for the planned Rare Diseases Partnership and ensure that research and innovation can deliver better outcomes for rare disease patients in Ireland.

  • Emerging Investigator Awards (EIA) 2024

    Supporting academic researchers at mid-stage of their research career transitioning to research independence and who can facilitate actionable knowledge in health research.

  • ERA4Health Joint Transnational Call (2024) “Modulation of brain ageing through nutrition and healthy lifestyle (NutriBrain)”

    The aim of the call is to support transnational research projects that focus on the improvement of cognitive brain ageing through nutrition and other lifestyle factors. Thereby it enables scientists from different countries to build a valuable collaboration on interdisciplinary research projects based on complementarities and sharing of expertise in the field of brain ageing, its related disorders, nutrition and lifestyle factors. Research projects should gain further insights into the modulation of brain aging by lifestyle factors and/or pilot test interventions based on the existing evidence in the literature or upscale existing pilot interventions that will help to lower the risk of cognitive impairment manifestations related to a pathological brain ageing.

  • Collaborative Doctoral Awards in Patient-focused Research (CDA) 2021 (next call expected to launch Q4 2024)

    Supporting excellent doctoral training programmes for future health researchers in the conduct of patient-focused research.

  • EJP Rare Diseases Joint Transnational Call (2023) “Natural History Studies addressing unmet needs in Rare Diseases”

    The objective of this call is to support efficient, innovative and high-quality natural history studies on rare diseases, which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy, and ultimately benefitting patients in the future.

  • EU Joint Programme – Neurodegenerative Disease Research (JPND) Joint Transnational Call (2023) “Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases”

    The aim of the call is to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that seek to improve the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases by applying multi-OMICs and Big data approaches in order to generate useful information for the diagnosis, treatment, prognosis, and drug discovery of neurodegenerative diseases.

  • ERA-NET Neuron Joint Transnational Call ‘’Mechanisms of Resilience and Vulnerability to Environmental Challenges in Mental Health” (2023)

    The aim of the call is to facilitate multinational, collaborative research projects that will address critical translational questions to improve our knowledge concerning neurobiological mechanisms involved in resilience or vulnerability to environmental challenges in mental health.

  • JPI AMR Joint Transnational Call (2023) “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”

    This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health antimicrobial resistance (AMR) surveillance. The results of the funded projects should contribute to improved understanding, monitoring, detection and mitigation of infection and AMR, or optimisation of AMU where efforts to curb AMR will have a global impact on human, animal and plant health and food safety and security.

  • ERA-NET-Cofund TRANSCAN-3 Joint Transnational Call (2023) “Translational research on cancer epigenetics”

    The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.